scholarly journals Associations of midpoint of sleep and night sleep duration with type 2 diabetes mellitus in Chinese rural population: the Henan rural cohort study

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Zhihan Zhai ◽  
Xiaotian Liu ◽  
Haiqing Zhang ◽  
Xiaokang Dong ◽  
Yaling He ◽  
...  

Abstract Background The study aimed to investigate the independent and combined effects of midpoint of sleep and night sleep duration on type 2 diabetes mellitus (T2DM) in areas with limited resources. Methods A total of 37,276 participants (14,456 men and 22,820 women) were derived from the Henan Rural Cohort Study. Sleep information was assessed based on the Pittsburgh Sleep Quality Index. Logistic regression models and restricted cubic splines were used to estimate the relationship of the midpoint of sleep and night sleep duration with T2DM. Results Of the 37,276 included participants, 3580 subjects suffered from T2DM. The mean midpoint of sleep among the Early, Intermediate and Late groups were 1:05 AM ±23 min, 1:56 AM ±14 min, and 2:57 AM ±34 min, respectively. Compared to the Intermediate group, adjusted odds ratios (ORs) and 95% confidence interval (CI) of T2DM were 1.13 (1.04–1.22) and 1.14 (1.03–1.26) in the Early group and the Late group. Adjusted OR (95% CI) for T2DM compared with the reference (7- h) was 1.28 (1.08–1.51) for longer (≥ 10 h) night sleep duration. The combination of late midpoint of sleep and night sleep duration (≥ 9 h) increased 38% (95% CI 10–74%) prevalence of T2DM. These associations were more obvious in women than men. Conclusions Late and early midpoint of sleep and long night sleep duration were all associated with higher prevalence of T2DM. Meanwhile, midpoint of sleep and night sleep duration might have combined effects on the prevalence of T2DM, which provided potential health implications for T2DM prevention, especially in rural women. Trial registration The Henan Rural Cohort Study has been registered at Chinese Clinical Trial Register (Registration number: ChiCTR-OOC-15006699). Date of registration: 2015-07-06.

2021 ◽  
Author(s):  
Zhihan Zhai ◽  
Xiaotian Liu ◽  
Haiqing Zhang ◽  
Xiaokang Dong ◽  
Yaling He ◽  
...  

Abstract Background: The study aimed to explore the independent and combined associations of midpoint of sleep and night sleep duration with type 2 diabetes mellitus (T2DM) in areas with limited resources.Methods: A total of 37,276 participants (14,456 men and 22,820 women) were derived from the Henan Rural Cohort. Information on sleep were collected using the Pittsburgh Sleep Quality Index. Logistic regression models and restricted cubic splines were used to estimate the relationship of the midpoint of sleep and night sleep duration with T2DM.Results: Of the 37276 included participants, 3580 subjects suffered from T2DM. The mean midpoint of sleep among Early, Intermediate and Late groups were 1.09 ± 0.39, 1.93 ± 0.24 and 2.95 ± 0.56, respectively. Compared to Intermediate group, adjusted odd ratios (ORs) and 95% confidence interval (CI) of T2DM were 1.13 (1.04-1.22) and 1.16 (1.05-1.28) in Early group and Late group. Adjusted OR (95% CI) for T2DM compared with reference (7- h) was 1.27 (1.08-1.50) for longer (≥10 h) night sleep duration. The combination of late midpoint of sleep and night sleep duration (≥9 h) increased 39% (95% CI: 11%-75%) prevalence for T2DM. These associations were more obvious in women than men.Conclusions: Late and early midpoint of sleep and long night sleep duration were all associated with the higher odds of T2DM. Meanwhile, midpoint of sleep and night sleep duration might be jointly associated with a higher prevalence of T2DM. Sleep may be a modifiable behavior that has potential health implications for T2DM.Clinical Trail Registration: The Henan Rural Cohort Study has been registered at Chinese Clinical Trial Register (Registration number: ChiCTR-OOC-15006699). Date of registration: 2015-07-06.


2019 ◽  
Vol 2019 ◽  
pp. 1-8 ◽  
Author(s):  
Xue Liu ◽  
Jingjing Jiang ◽  
Xiaotian Liu ◽  
Zhicheng Luo ◽  
Yan Wang ◽  
...  

Objective. The aim of the study was to investigate the independent and combined effects of the cortisol-to-cortisone ratio (F/E) and 11-deoxycortisol on prediabetes and type 2 diabetes mellitus (T2DM) among different genders. Methods. A case-control study was performed including 2676 participants from the Henan Rural Cohort Study. Liquid chromatography-tandem mass spectrometry was used to assess serum cortisol, cortisone, and 11-deoxycortisol. Conditional logistic regression was performed to estimate the associations between hormones and outcomes. Results. After adjusting for multiple variables, the negative associations of F/E and 11-dexyocortisol with T2DM were observed in females (T3 vs. T1: OR=0.56, 95% CI: 0.39-0.80 for F/E; T3 vs. T1: OR=0.44, 95% CI: 0.27-0.73 for 11-dexyocortisol). However, only 11-dexyocortisol showed a negative association with prediabetes both in males and females. Compared with the combination of low F/E and 11-dexyocortisol, the combination of middle F/E and high 11-dexyocortisol was significantly associated with prediabetes (OR=0.29, 95% CI: 0.12-0.71) in males. Furthermore, the combination of high F/E and 11-dexyocortisol was associated with the lowest odds of prediabetes (OR=0.39, 95% CI: 0.21-0.73) and T2DM (OR=0.25, 95% CI: 0.12-0.52) in females. Conclusions. Serum F/E level was negatively associated with T2DM only in females whereas serum 11-deoxycortisol level was negatively associated with prediabetes in males and with prediabetes and T2DM in females. Additionally, their combination has a synergistic effect on T2DM.


2021 ◽  
Vol 13 (1) ◽  
Author(s):  
Lauren Parlett ◽  
Qinli Ma ◽  
Qian Shi ◽  
Geoffrey Crawford ◽  
Laura Herrera Scott ◽  
...  

AbstractThis claims-based retrospective cohort study examined the prevalence and incremental impact of non-alcoholic steatohepatitis among children with type 2 diabetes mellitus in the United States. Although diagnoses of non-alcoholic steatohepatitis were not common among diabetic children, it was associated with significantly higher incremental healthcare cost and risk of hospitalization.


2021 ◽  
Vol 160 (6) ◽  
pp. S-30
Author(s):  
Frederikke Sch⊘nfeldt Troelsen ◽  
Henrik Toft S⊘rensen ◽  
Lars Pedersen ◽  
Rune Erichsen

Sign in / Sign up

Export Citation Format

Share Document